ArticleSensors (Basel, Switzerland)2022
A Hybrid Bipolar Active Charge Balancing Technique with Adaptive Electrode Tissue Interface (ETI) Impedance Variations for Facial Paralysis Patients.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- 3.6 mW Active-Electrode ECG/ETI Sensor System Using Wideband Low-Noise Instrumentation Amplifier and High Impedance Balanced Current Driver.Sensors (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional electrical stimulation (FES) is a safe, effective, and general approach for treating various neurological disorders. However, in the case of FES usage for implantable applications, charge balancing is a significant challenge due to variations in the fabrication process and electrode tissue interface (ETI) impedance. In general, an active charge balancing approach is being used for this purpose, which has limitations of additional power consumption for residual voltage calibration and undesired neurological responses. To overcome these limitations, this paper presents a reconfigurable calibration circuit to address both ETI variations and charge balancing issues. This reconfigurable calibration circuit works in two modes: An impedance measurement mode (IMM) for treating ETI variations and a hybrid charge balancing mode (HCBM) for handling charge balance issues. The IMM predicts the desired stimulation currents by measuring the ETI. The HCBM is a hybrid combination of electrode shorting, offset regulation, and pulse modulation that takes the best features of each of these techniques and applies them in appropriate situations. From the results, it is proved that the proposed IMM configuration and HCBM configuration have an optimal power consumption of less than 44 μW with a power ratio ranging from 1.74 to 5.5 percent when compared to conventional approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.